Skip to main content
. 2007 Jul 18;2007(3):CD004404. doi: 10.1002/14651858.CD004404.pub3

Strangert 1969.

Methods Quasi‐randomised controlled trial
Participants Inclusion criteria: children admitted with clinical pertussis 
 Exclusion criteria: children who received chloramphenicol or ampicillin prior to their stay in hospital or were discharged before the course of therapy had been completed
Interventions Treatment group: ampicillin 75 to 100 mg/kg/day divided in 4 doses for 6 days 
 Controlled group: chloramphenicol 75 to 100 mg/kg/day divided in 4 doses for 6 days 
 Children under 6 months of age were also given immunoglobulin against whooping cough each other day on altogether 3 occasions
Outcomes Microbiological eradication, adverse reactions, complications (secondary infections)
Notes This is quasi‐randomised study for treatment of pertussis. Immunisation status not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Method of randomisation: alternation of patients (each second child admitted with whooping cough was treated with ampicillin)
Allocation concealment (selection bias) High risk High risk
Blinding (performance bias and detection bias) 
 All outcomes High risk Blinding of intervention: no. Blinding of outcome measure: no
Incomplete outcome data (attrition bias) 
 All outcomes High risk Complete follow up: no
Selective reporting (reporting bias) High risk  

DTP: diphtheria‐tetanus‐pertussis 
 EST: erythromycin estolate 
 ETH: erythromycin ethylsuccinate 
 t.d.s: three times a day